The Astrocytoma market is anticipated to increase, due to an increase in the incidence of brain tumors and the anticipated launch of novel therapies.
DelveInsight’s Astrocytoma market report thoroughly explains Astrocytoma, historical and forecasted epidemiology, as well as the Astrocytoma market trends in the 7MM.
Some of the Key Highlights from the Astrocytoma Market Report
- According to Crocetti et al., astrocytic tumor incidence rates vary significantly among European areas, ranging from 3/100,000 in Eastern Europe to 5/100,000 in the United Kingdom.
- According to the National Organization for Rare Disorders (NORD), Anaplastic astrocytoma and glioblastoma multiforme are expected to affect 5-8 persons per 100,000 in the general population.
- Leading players in the Astrocytoma market include Denovo Biopharma, Orbus Therapeutics, Diffusion Pharmaceuticals, and others.
- Key Astrocytoma therapies in the pipeline include DB102, Eflornithine, Trans Sodium Crocetinate (TSC), and others.
- The US FDA and EMA designated DB102 (Denovo Biopharma) as an orphan drug for DLBCL and glioblastoma multiforme (GBM), and the US FDA granted it Fast Track Designation.
Have queries? Request for the sample @ Astrocytoma Market Outlook
View Report: https://www.delveinsight.com/report-store/astrocytoma-market
Astrocytoma Overview
Astrocytoma is a tumor that can develop in the brain or the spinal cord. It starts in nerve-supporting cells called astrocytes and is the most frequent type of brain tumor in adults. Astrocytoma is classified as grade 1 (most benign) to grade 4 (most malignant) by the World Health Organization (WHO).
Astrocytoma Epidemiology Segmentation
The Astrocytoma report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
- Astrocytoma Total Incident Cases
- Astrocytoma Grade-Specific Cases
- Astrocytoma Total Diagnosed Cases
- Astrocytoma Gender-Specific Cases
- Astrocytoma Line Wise Treated Cases
Astrocytoma Treatment Landscape
The current Astrocytoma treatment options include:
- Surgery
- Steroids
- Chemotherapy
- Radiotherapy
- Bevacizumab (Avastin)
- Off Label Therapies (Procarbazine hydrochloride)
View Report: https://www.delveinsight.com/report-store/astrocytoma-market
The Astrocytoma market will expand during the forecast period, 2021–2030, due to an increase in the incidence of brain tumors and the anticipated launch of novel therapies such as DB102, Eflornithine, Trans Sodium Crocetinate (TSC), and others.
Discover more about the future market share of the drugs @ Astrocytoma Market Analysis
Astrocytoma Pipeline Therapies and Key Companies
- DB102: Denovo Biopharma
- Eflornithine: Orbus Therapeutics
- Trans Sodium Crocetinate (TSC): Diffusion Pharmaceuticals
View Report: https://www.delveinsight.com/report-store/astrocytoma-market
Table of Contents
| 1. | Key Insights |
| 2. | Executive Summary of Astrocytoma |
| 3. | SWOT Analysis of Astrocytoma |
| 4. | Astrocytoma: Market Share (%) Distribution Overview at a Glance: By Country |
| 5. | Epidemiology and Market Methodology |
| 6. | Astrocytoma: Disease Background and Overview |
| 7. | Epidemiology and Patient Population |
| 8. | Epidemiology Scenario: 7MM |
| 9. | The United States Epidemiology |
| 10. | EU-5 Epidemiology |
| 11. | Japan Epidemiology |
| 12. | Current Treatment Practices |
| 13. | Unmet Needs |
| 14. | Patient Journey of Astrocytoma |
| 15. | Key Endpoints in Astrocytoma Clinical Trials |
| 16. | Marketed Therapies |
| 17. | Emerging Therapies |
| 18. | Conjoint Analysis of Astrocytoma |
| 19. | Astrocytoma: Eight Major Market Analysis |
| 20. | 7MM Market Size |
| 21. | United States Market Size |
| 22. | EU-5 Market Size |
| 23. | Japan Market Size |
| 24. | Market Access and Reimbursement of Astrocytoma Therapies |
| 25. | Market Drivers |
| 26. | Market Barriers |
| 27. | Appendix |
| 28. | DelveInsight Capabilities |
| 29. | Disclaimer |
| 30. | About DelveInsight |
DelveInsight’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.
Other Reports:
- Diagnostic Imaging Equipment Market
- Defibrillators Market
- Diagnostic Imaging Equipment Market
- Pulse Oximeters Market
- Achromatopsia Market
- Cataplexy Market
- Contusion Market
- Osteosarcoma Market
- Acute Lung Injury Market
- Intravenous Immunoglobulin Market
- Airway Stent Market
- Chronic Rhinosinusitis Phenotype with Nasal Polyps Market
- Neurostimulation Devices Market
- Capnography Devices Market
- Implantable Infusion Pumps Market
- Familial Primary Pulmonary Hypertension Market
- Giant Papillary Conjunctivitis Market
- Epithelioid Sarcoma Market
Related Blogs:
- Most Promising Applications of Artificial Intelligence (AI) in Healthcare Segment
- Mapping the Biggest Pharmaceutical Companies by Continents
- Widespread Usage of HPV Vaccine Reduces Cervical Cancers and Precancers
- Major Drugs Decisions for Cardiovascular Diseases to Watch Through 2022
- Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021
- Evaluation of Rapidly Evolving Parkinson’s Disease Therapeutic Market
- Cybersecurity in Healthcare: Major Threats and Challenges
- Top Drugs To Watch in HIV (2025)
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Connect With Us at:
Site Title 